DK1965669T3 - Præparat der omfatter oligosaccharider som oplöselige kostfibre til anvendelse mod muskeltab - Google Patents

Præparat der omfatter oligosaccharider som oplöselige kostfibre til anvendelse mod muskeltab

Info

Publication number
DK1965669T3
DK1965669T3 DK06824315T DK06824315T DK1965669T3 DK 1965669 T3 DK1965669 T3 DK 1965669T3 DK 06824315 T DK06824315 T DK 06824315T DK 06824315 T DK06824315 T DK 06824315T DK 1965669 T3 DK1965669 T3 DK 1965669T3
Authority
DK
Denmark
Prior art keywords
oligosaccharides
composition
dietary fibers
soluble dietary
use against
Prior art date
Application number
DK06824315T
Other languages
Danish (da)
English (en)
Inventor
Marchel Gorselink
Helvoort Adrianus Lambertus Van
Robert Johan Joseph Hageman
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36028309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1965669(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1965669T3 publication Critical patent/DK1965669T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/729—Agar; Agarose; Agaropectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
DK06824315T 2005-12-16 2006-12-18 Præparat der omfatter oligosaccharider som oplöselige kostfibre til anvendelse mod muskeltab DK1965669T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05112336 2005-12-16
PCT/NL2006/050320 WO2007069900A1 (en) 2005-12-16 2006-12-18 Use of soluble dietary fibres against muscle wasting

Publications (1)

Publication Number Publication Date
DK1965669T3 true DK1965669T3 (da) 2009-10-05

Family

ID=36028309

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06824315T DK1965669T3 (da) 2005-12-16 2006-12-18 Præparat der omfatter oligosaccharider som oplöselige kostfibre til anvendelse mod muskeltab

Country Status (17)

Country Link
US (2) US8143235B2 (de)
EP (1) EP1965669B1 (de)
JP (1) JP2009519328A (de)
CN (2) CN102948659B (de)
AT (1) ATE441333T1 (de)
AU (1) AU2006325591B2 (de)
BR (1) BRPI0619947B1 (de)
CA (1) CA2633292C (de)
DE (1) DE602006008985D1 (de)
DK (1) DK1965669T3 (de)
ES (1) ES2332149T3 (de)
IL (1) IL192219A (de)
NZ (1) NZ569169A (de)
PL (1) PL1965669T3 (de)
RU (1) RU2450815C2 (de)
WO (1) WO2007069900A1 (de)
ZA (1) ZA200805905B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP4610499B2 (ja) * 2006-02-27 2011-01-12 ポーラ化成工業株式会社 食品組成物
WO2009153064A2 (en) * 2008-06-19 2009-12-23 N.V. Nutricia Liquid nutritional composition for bariatric surgery patients
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
WO2010002242A1 (en) 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
BRPI0915974A2 (pt) * 2008-07-18 2017-05-30 Hill´S Pet Nutrition Inc métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
EP2563372A4 (de) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc Präbiotische formulierungen und verwendungsverfahren dafür
CN103476274A (zh) * 2011-04-18 2013-12-25 雀巢产品技术援助有限公司 具有α-HICA和α-酮戊二酸的营养组合物
WO2014007606A1 (en) * 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
ES2402643B1 (es) 2012-12-24 2014-01-24 Universitat De Lleida Combinación de fibra anticolesterolémica
MY186844A (en) 2014-07-09 2021-08-25 Cadena Bio Inc Oligosaccharide compositions and methods for producing thereof
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
JP2018517677A (ja) 2015-04-23 2018-07-05 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン治療剤及び治療方法
KR102548553B1 (ko) * 2016-04-14 2023-06-27 듀폰 뉴트리션 바이오사이언시즈 에이피에스 제지방 체중을 증가시키기 위한 비피더스균
CN106387923B (zh) * 2016-09-07 2019-12-20 中国农业大学 一种富含半乳甘露聚糖的可溶性膳食纤维及其制备方法
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
DE102017201713A1 (de) * 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
AU2019376144A1 (en) * 2018-11-08 2021-05-13 Dsm Ip Assets, B.V. Methods of supporting gastrointestinal homeostasis
AU2019376668A1 (en) * 2018-11-08 2021-05-13 Dsm Ip Assets, B.V. Methods of selectively modulating gastrointestinal microbial growth
TW202108007A (zh) * 2019-05-24 2021-03-01 比利時商科舒克拉 格魯普瓦爾科迎有限公司 包含纖維及蛋白質之組合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5589468A (en) 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
ATE218065T1 (de) * 1996-08-09 2002-06-15 Mannatech Inc Zusammensetzungen auf pflanzliicher kohlenhydratbasis als nahrungsergänzungsstoffe
US5776524A (en) 1996-10-30 1998-07-07 The Iams Company Process for treating small intestine bacterial overgrowth in animals
US5817695A (en) * 1997-12-24 1998-10-06 Pellico; Michael A. Nutritional product with high fat, low carbohydrate and amino acid imbalance
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
GB2364642B (en) * 2000-01-07 2004-10-27 Bioenergy Inc Compositions for enhancing the immune response
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US6592863B2 (en) 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
JP2003137790A (ja) * 2001-11-01 2003-05-14 Mie Kariyou Kk β−２，１（β２→β１）結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬
JP2004051942A (ja) * 2002-05-29 2004-02-19 Daicel Chem Ind Ltd 分散体及びそれを用いた成形体の製造方法
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
DK1643861T3 (da) * 2003-07-15 2011-07-25 Nestec Sa Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter
CN1871015B (zh) * 2003-10-24 2010-06-16 努特里奇亚有限公司 免疫调节性寡糖
NZ546785A (en) * 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
AU2006237738B2 (en) * 2005-04-21 2011-09-29 N.V. Nutricia Nutritional supplement for HIV patients
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system

Also Published As

Publication number Publication date
ATE441333T1 (de) 2009-09-15
IL192219A (en) 2011-08-31
NZ569169A (en) 2012-01-12
EP1965669A1 (de) 2008-09-10
CN101374426A (zh) 2009-02-25
AU2006325591B2 (en) 2012-07-12
CN102948659A (zh) 2013-03-06
CA2633292A1 (en) 2007-06-21
CA2633292C (en) 2015-04-28
JP2009519328A (ja) 2009-05-14
ZA200805905B (en) 2009-10-28
RU2450815C2 (ru) 2012-05-20
WO2007069900A1 (en) 2007-06-21
BRPI0619947A2 (pt) 2011-10-25
EP1965669B1 (de) 2009-09-02
CN101374426B (zh) 2012-11-28
CN102948659B (zh) 2014-04-23
US8143235B2 (en) 2012-03-27
US9555059B2 (en) 2017-01-31
PL1965669T3 (pl) 2010-02-26
US20090203573A1 (en) 2009-08-13
BRPI0619947B1 (pt) 2023-10-10
IL192219A0 (en) 2008-12-29
US20120165243A1 (en) 2012-06-28
RU2008129102A (ru) 2010-01-27
ES2332149T3 (es) 2010-01-27
DE602006008985D1 (de) 2009-10-15
AU2006325591A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
DK1965669T3 (da) Præparat der omfatter oligosaccharider som oplöselige kostfibre til anvendelse mod muskeltab
DK1841332T3 (da) Fortykningskomposition til dysfagi patienter
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CR20150097A (es) Composición inmunogénica
ATE554114T1 (de) Copolymer mit zwitterionischen einheiten und anderen einheiten, das copolymer umfassende zusammensetzung und verwendung
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
WO2004089353A3 (en) Methods for treatment of parkinson's disease
ATE548020T1 (de) Kombinationen für orale zusammensetzungen, ihre herstellung und verwendung
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
IL172631A0 (en) Gaboxadol for treating depression and other affective disorders
CY1109772T1 (el) Χρηση βακτηριδιακων πολυσακχαριτων για αναστολη βιομεμβρανων
TW200715966A (en) Synergistic fungicidal active compound combinations
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
ATE442153T1 (de) Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans
BRPI0717458A2 (pt) Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional.
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
JP2007308378A5 (de)
ATE497519T1 (de) Kationische flüssige stärkehaltige zusammensetzung und verwendungen davon
ATE518544T1 (de) Rotbusch-extrakt gegen diabetes
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
MXPA05013969A (es) Poliorganosiloxanos.
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent
RS20050911A (en) Gaboxadol for treating depression and other affective disorders
BR8202568U (pt) Grampo dentado para fixação de folhas de tabaco
NO20061427L (no) Kombinasjonen av en serotonin-reoppttaksinhibitor og amoxapin